# Effects of Sulforaphane for Patients With Chronic Kidney Disease

> **NCT04608903** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Universidade Federal Fluminense** · enrollment: 25 (estimated)

## Conditions studied

- Chronic Kidney Disease

## Interventions

- **DIETARY_SUPPLEMENT:** L-sulforaphane 1%
- **DIETARY_SUPPLEMENT:** Placebo Group

## Key facts

- **NCT ID:** NCT04608903
- **Lead sponsor:** Universidade Federal Fluminense
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-12-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2025-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04608903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04608903, "Effects of Sulforaphane for Patients With Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04608903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*